2022 International Plasma Protein Congress
14-15 June | Berlin

GPS2020 logo

On 14-15 June 2022, at the International Plasma Protein Congress, policymakers, stakeholders, patient groups and industry come together to discuss the need to increase plasma collection in Europe to facilitate patient access to plasma-derived medicinal products (PDMPs). This year, the congress takes place in Berlin and will be opened by the German Minister of Health discussing German plasma collection and PDMP ecosystem.

On day 1, we will look into how plasma collection is organised in many and partnerships between national authorities and the private sector to increase plasma collection in a country. We also explore how forthcoming changes to EU legislation could help Europe reduce its dependency on third countries for plasma.

On day 2, we look into the value that PDMPs bring to patients and society and the clinical need for PDMPs and how patient access can be optimised. We see how within regulatory policy, there are many opportunities to improve availability of plasma and access to PMDP; for example, with a mutual recognition agreement on GMP inspections for PDMPs and plasma.

And finally, given that safety of PDMPs, next to donor safety, is in the core of our mission, we will have an expert panel discuss the latest developments in pathogen safety and pathogen reduction in PDMPs, such as SARS-COV-2 and vCJD.

With the imminent revision of EU legislation such as the Blood Directive and General Pharmaceutical legislation and given the EU’s path towards strategic autonomy around critical medicines, we have a historic opportunity to increase availability of plasma and patient access to PDMPs. Join us at the congress for these important discussions and great networking.

Meeting Programme*

Day One - Tuesday, 14 June 2022

Time (CET) 

07:00-17:30 On-site registration open
08:30-09:00

Opening - Revising EU Legislation: A One-Off Opportunity to Increase Plasma Collection?



Welcome
Maarten Van Baelen, Executive Director, Head of Europe - PPTA

Opening speech
Prof. Dr. Karl Lauterbach, Minister of Health - Germany

09:00-10:45 SESSION 1 : Paving the Way in Europe Plasma Collection in Germany - Tried and Tested: A success story?
CHAIR: Dr. Stephan Walsemann - Scinomed GmbH
Germany has a well-functioning plasma collection system based on the co-existence and cooperation of all plasma collection stakeholders (ARGE Plasmapherese). Nevertheless, even well-functioning systems need regular updates to meet current and future needs.

Historic Overview - Presentation

Pros and Cons Panel Discussion - Industry perspective
Svenja Barckhausen, Member of the Board - Haema AG

Pros and Cons Panel Discussion - Patient Perspective
Dr. Gerd Klock, dsai-regional group leader from Frankfurt/Mainz

Pros and Cons Panel Discussion - Policy Perspective
TBC

Pro and Cons Panel Discussion - Donor Perspective
Michael Fuhr, Plasma donor

Pros and Cons Panel Discussion - Industry perspective
Stephan Proske, Director Sales & Marketing Western Europe - Kedrion Biopharma

10:45 -11:30 Networking Break

An opportunity for attendees to network with meeting participants, speakers, and sponsors.

Sponsored by Haemonetics Logo RED

11:30-13:00 SESSION 2: Plasma collection models: Public and Private Sectors: Coexistence, partnership or silo - Seeking the optimum model
CHAIR: Alexa Wetzel, Director, Lead for European Plasma - PPTA
There are different blood and plasma collection systems worldwide. There is no one-size-fits-all model. Every country has its own health system structure. There is no single solution to ensure stable and safe access to plasma-derived medicinal products for patients. This is why in this session we are presenting different collection models, providing examples within the framework of either a public or a public-private coexistence structure.

Plasma collection in Hungary
Miklos Szolnoky - Biotest

Plasma collection in Egypt
Dr Ahmed Serag - GRIFOLS Egypt Plasma Derivatives

Plasma collection in Ukraine
Oksana Muliarchuk - Biopharma Plasma

Plasma collection in the United Kingdom
Gerard Gogarty - NHS Blood and Transplant

13:00-14:15 Networking Lunch
An opportunity for attendees to network with meeting participants, speakers, and sponsors.
14:15-15:45 SESSION 3: EU Pharma Strategy - Open strategic autonomy: Could the EU approach to starting materials boost plasma collection in Europe?
CHAIR: Leo Cendrowicz - The Independent – i – The Brussels Times
The EU Pharma strategy calls for strategic autonomy on starting materials for medicines in the EU and a reduction in dependency on third countries. The EU has a reliance of 30% (around 3.8 million liters) on the US. In this session, we will discuss how increasing plasma collection in the EU contributes to the EU's goals of that open strategic autonomy, how it improves patient access to PDMPs, and how the private sector is committed to collecting more plasma in Europe.

Stefaan van der Spiegel, Team Leader - Substances of human origin, DG Health & Food Safety – European Commission

Matthew Hotchko President - The Marketing Research Bureau

Martine Pergent, President - IPOPI

David Bell, Chief Innovation Officer & General Counsel - Grifols

15:45-16:15 Networking Break

An opportunity for attendees to network with meeting participants, speakers, and sponsors.

Sponsored by Haemonetics Logo RED

16:15-17:30 SESSION 4: EU Pharma Strategy - Europe's industrial policy Progressing From Plasma to Product Establishing Successful Fractionation Plants: Lessons from the Past and Present
CHAIR: Leo Cendrowicz - The Independent – i – The Brussels Times
With a total of 37 plants, Europe has currently one of the strongest plasma fractionation plant footprints in the world. However, there remain European countries that do not at present have their own fractionation plants, but who plan to set them up. Through utilising their own plasma resources, the aim is to control the manufacture of PDMPs in their own country. Setting up a fractionation plant is, however, very complex, expensive and time-consuming. This interactive session strives to discuss aspects of how to be successful and how to avoid failure, amidst the myriad challenges to the availability of sufficient plasma in the EU, not least due to the pandemic.

Patrick Robert, Consultant - The Marketing Research Bureau

Radosław Sierpiński, President of Medical Research Agency, Prime Minister's High Representative for Development of Biotechnology - Poland

Peter Janssen, Executive Vice President CDMO Business / GM Belgium - Prothya Biosolutions

17:30-17:45 End of the day closure - Hilfenhaus Award
Presented by Oliver Schmitt, Chair - PPTA EU Advisory Committee; General Manager - CSL Behring
17:45-19:15 Networking Reception

An opportunity for attendees to network with meeting participants, speakers, and sponsors.

Sponsored by

Day Two - Wednesday, 15 June 2022

Time (CET) 

08:00-12:00 On-site registration open
09:00 - 09:30

Opening



Welcome
Oliver Schmitt, Chair - PPTA European Board of Directors; General Manager - CSL Behring (TBC)

Keynote address
Andreas Glück, Member of the European Parliament - Renew Europe, Germany

09:30 - 10.45 SESSION 5 : EU Pharma Strategy - A Vision Beyond the legislation Improving the Access Pathway for Plasma Protein Therapies
CHAIR: Tomasz Kluszczyński Partner - Vintura
One of the EU’s Pharmaceutical Strategy key objectives is to ensure access to critical medicines for patients, including plasma-derived medicinal products (PDMPs). These medicines are unique biological therapies derived from human plasma and are used to treat patients (300,000 in Europe) with rare, often genetic, life-threatening conditions. Immunoglobulin (IG) therapies, which are used to treat dysfunctional immune systems, represent a lead product category amongst PDMPs. Patients are, however, facing access challenges and a debate on prioritisation and optimising the use of IG has already begun. Restricting patient access would lead to lower socio-economic benefits and is not the solution to an ever-growing clinical need. This session provides a timely opportunity to reflect on how to take up this debate. Healthcare professionals, authorities, together with patients and industry representatives, will share their analyses of the current situation and propose solutions about how to enhance patient access to PDMPs. We will discuss these challenges and opportunities in the context of the EU Pharmaceutical Strategy, which highlights the importance of access to medicines and the goal to reach an EU Open Strategic Autonomy for starting materials for medicines, such as plasma.

Lieven Annemans, Professor health Economy - UGent

Mark Stettner, Senior Consultant, Neurologist and Associate professor - Department of Neurology, University of Essen

Martin van Hagen, Head of Clinical Immunology, Internal Medicine/Immunology - University Medical Center Rotterdam

Jean Philippe Plançon - EPODIN

César Hernández García, Head of Department, Department of Medicines for Human Use - Spanish Agency for Medicines and Health Products (AEMPS)

Roberto Tana, Global Marketing Director | International Contract Manufacturing Director - Kedrion Biopharma

10:45 -11:30 Networking Break

An opportunity for attendees to network with meeting participants, speakers, and sponsors.

Sponsored by Haemonetics Logo RED

11:30 - 12:45 SESSION 6: EU files: The Uniqueness of Plasma - An Essential Differentiation from Blood from a Policy Perspective
CHAIR: Faraz Kermani, Head Global Communications - PPTA
In view of the ongoing revision of the EU general pharmaceutical legislation and blood Directive, this session aims to highlight how having clear definitions and differentiating between blood for transfusion and plasma for manufacturing could enhance access to PDMPs for patients. Using specific examples from the relevant regulatory provisions in the EU Blood Directive and the general EU pharmaceutical legislation, this session will highlight how specific provisions in the EU legislation would reduce regulatory uncertainty, make more plasma available for manufacturing of plasma-derived medicinal products (PDMPs), ultimately benefitting patients in the EU.

ECJ decision and how legal definitions are outlined in other legal frameworks
Bita Bakhschai, Specialist lawyer for medical law, Commercial Lawyer - Univ. Bayreuth

How better definitions could ensure global cooperation
Tom Brusselmans -European Medicines Agency

Industry perspective, current hurdles and need for a global collaboration
Jens Rehbein Director, Plasma Lead, Global Regulatory Affairs - CSL Behring

Patient perspective, the importance of differentiation to increase patient access
Leire Solis, Senior Manager, Health Policy and Advocacy - IPOPI

Policymaker’s perspective in the context of the EU files revision
Stefaan van der Spiegel, Team Leader - Substances of Human Origin, DG Health & Food Safety – European Commission

12:45 - 14:00 Networking Lunch
An opportunity for attendees to network with meeting participants, speakers, and sponsors.
14:00- 15:20 SESSION 7: Improving Pathogen Safety - Key Highlights and Developments
CHAIR: Dominika Misztela, Senior Director Lead for European Regulatory & Quality - PPTA
This expert session will address the importance of constant pathogen safety vigilance for the plasma industry and highlight key regulatory decision making and challenges, showcasing UK plasma as an example.

Emerging viruses, and consequences for the safety and efficacy of plasma products
Thomas R. Kreil, Chair - PPTA Global Pathogen Safety Committee; Associate Professor of Virology, Vice President - Takeda

Anti-SARS-COV-2 antibodies in IG preparations and therapeutic implications
Eleonora Widmer, PPTA GPSC member; Senior Director, Global Pathogen Safety R&D - CSL

The curious case of UK plasma
David McIntosh, Chair - UK Plasma Action

Mission and role of Arbeitskreis Blut: Pathogen Safety of Blood Components
Ruth Offergeld, Chair - Arbeitskreis Blut

15:20- 15:30 Closure of IPPC 2022

*Subject to change 

Registration

Registration for the IPPC includes access to all general sessions, the exhibit hall, and the Awards Reception on 14 June (you must be registered for the IPPC in order to attend the Awards Reception). Individuals not registered for the IPPC will be given the opportunity to register on-site or will not be granted access to these events.

Registration type
PPTA Members
Non-members
Emeritus
Patient representatives, Government, and Health care providers *
Early bird rate
€1200
€1700
500
No cost*
After 7 April 2022
€1400
€1900
€500
No cost*
On-site
€1500
€2000
€600
No cost*

*Complimentary registration subject to verification

Terms and Conditions

Early Bird registration: Payment must be received by 7 April 2022 in order to receive the discounted rate.

Registration type: PPTA reserves the right to confirm registration type and charge appropriately.

Substitutions: Substitutions will not be allowed on-site. Notification of substitutions must be received by 6 June 2022.

Cancellations: Cancellations must be received in writing by 6 June 2022 and will be subject to an administrative fee of 250 €. Cancellations after 6 June 2022 will not be refunded. Full refunds will be provided should the meeting be cancelled due to extenuating circumstances which prohibit the Congress from taking place, including but not limited to the coronavirus pandemic.

Press: All press must apply for credentials prior to the event. Please contact Faraz Kermani for more information.

Data protection: The personal information provided will be used for PPTA purposes only.


Hotel Information

The International Plasma Protein Congress will be held at the:
Berlin Marriott Hotel
Inge-Beisheim-Platz 1 Berlin, Germany 10785
Tel: +49 30 220000


Reservations
The Berlin Marriott Hotel is offering a special rate for IPPC attendees of 250-270 EUR/night (plus tax) for the dates of 11 June to 16 June 2022. This special rate is available through 13 May 2022 or until the PPTA room block is sold out, whichever occurs first.

Additional information
The Berlin Marriott Hotel is located 40km (25mi) from the Berlin Brandenburg Airport, approximately 35-minute taxi drive.


Sponsorship & Exhibiting Opportunities

Take advantage of the premier opportunity to effectively position your brand with key leaders of the plasma protein therapeutics industry. The International Plasma Protein Congress (IPPC), to be held on 14 and 15 June 2022 at the Berlin Marriott Hotel, in Germany, offers a variety of opportunities to expand your reach.

Exhibitor & Sponsor Registration Form

Deadline to register as a Sponsor/Exhibitor is 8 April 2022

Exhibitor Benefits

PPTA provides each company exhibiting with:

Sponsor Recognition:

  • Sponsor visibility on rolling PowerPoint in main conference room
  • Company logo on PPTA Global website
  • Recognition in IPPC e-blasts
  • Signage in Congress Exhibit Hall or Foyer
  • Company logo and a brief word description in the Congress App

Amenities package includes: skirted table, two chairs, waste basket, and electricity.

Booth Traffic Generation Programme: This is an incentive programme to draw attendees to your booth. Attendees will visit each booth to obtain vendor signature and will be entered into a draw to win an Apple Watch! The winner will be announced during the closing announcements on 15 June 2022.

Exhibit Sponsor Levels

Gold Sponsor: € 12,000

50% discount is offered to the Plasma Protein Forum (PPF) Diamond Sponsors
20% discount is offered to the PPF Platinum Sponsors

Gold level includes:

  • Booth Space (3 x 2 m) in the Exhibit Hall
    • Exhibit Hall will include the lunches, coffee breaks and reception (#1-6)
  • A 30-60 second commercial video to be played at the end of a session in the Congress room. The video will also be available at the PPTA Global website and within the meeting App.
    • Must provide a clickable link to your video of choice, which must be hosted by you on an alternative platform such as Vimeo or YouTube.
  • Supplementary visibility on directional signage
  • Four Exhibitor registrations (complimentary access to the Congress)
  • Additional registrations at Early Bird rate:
    • Members € 1,200
    • Non-members € 1,700
Silver Sponsor: € 8,000

Silver level includes:

  • Tabletop Space (180 x 50 cm) in the Exhibit Foyer (A-E)
    • Note: Your exhibit materials must fit on the table only
  • A 30-60 second commercial video available at the PPTA Global website and within the meeting App.
    • Must provide a clickable link to your video of choice which must be hosted by you on an alternative platform such as Vimeo or YouTube.
  • Three Exhibitor registrations (complimentary access to the Congress)
  • Additional registrations at Early Bird rate:
    • Members € 1,200
    • Non-members € 1,700


Exhibit Schedule

The Congress draws attendees to your exhibit with these scheduled events. This schedule is indicative and is subject to change until the final program is available.

Monday, 13 June
Monday, 13 June

Time (CET)

Exhibitor Move-in 16.00 – 21.00
Tuesday, 14 June
Tuesday, 14 June

Time (CET)

Exhibit Hall Hours
Start of Meeting
Networking Break
Networking Lunch
Networking Break
Reception


09:00
10:45 – 11:30
12:45 – 14:00
15:45 – 16:15
17:45 – 19:15

Wednesday, 15 June
Wednesday, 15 June

Time (CET)

Exhibit Hall Hours
Start of Meeting
Networking Break
Networking Lunch
Networking Closure Break
Exhibitor Move-out


09:00
10:45 – 11:30
12:45 – 14:00
15:20
16:30 – 17:30


Exhibit Hall Floor Plan

Please select your 1st, 2nd, and 3rd choice on the registration form.


Networking Sponsorships

Increase your visibility at the Congress with these high visibility, high impact opportunities.

All Networking Sponsors will receive:

  • Visibility on rolling PowerPoint in main conference room
  • Company logo on PPTA Global website
  • Recognition in IPPC e-blasts
  • Company logo and a brief word description in the Congress App
Cocktail Reception (€ 10,000)

Sponsor the opening night reception. At the Congress’s most attended event, your company will maximise exposure among attendees.

  • Recognition during the Congress and at the reception
  • Your company logo at all buffet stations and tables
Lunch (€ 5,000 each)

Increase your visibility at the Congress by sponsoring the lunch on day one and/or day two!

  • Recognition during the Congress and at the lunch
  • Your company logo at all buffet stations and tables
Power Networking Break (€ 2,000 each)

Attendees flock to networking breaks and that means your company gets noticed. There are a total of 4 breaks during the Congress. Choose one, or choose them all!

  • Recognition during the Congress and at the beginning of each break
  • Your company logo at each refreshment break station


Product & Other Sponsorships

Product sponsorships are walking billboards for your company. All sponsored products are distributed to every attendee and feature your company name and/or logo alongside (if space permits) the Congress logo. Reserve early, limited availability. For production planning purposes the deadline to submit your branded logo is 15 April 2022.

All Product Sponsors will receive:

  • Visibility on rolling PowerPoint in main conference room
  • Company logo on PPTA Global website
  • Recognition in IPPC e-blasts
  • Company logo in the Congress App
Bag (€ 7,000)
  • Includes 1 registration (complimentary access to the Congress)
Meeting Folder (€ 6,000)
  • Includes 1 registration (complimentary access to the Congress)
IPPC App (€ 5,000)
  • Includes 1 registration (complimentary access to the Congress)
  • Your company name/logo will be visible at the bottom of every page
  • Provide suitable content for 1-page advertisement (will be reviewed and approved by PPTA legal counsel)
  • Provide a 30-60 second commercial video, which will be available at the PPTA global website and within the meeting App.
    • Must provide a clickable link to your video of choice which must be hosted by you on an alternative platform such as Vimeo or YouTube.
  • Congress presentations will be available on the app only
Lanyard (€ 3,500)
  • Attached to each attendee name badge.
NEW! “Ship your own” Product Opportunity (€ 3,000)
  • Ship your own product in advance and PPTA will include it in the IPPC handout materials. Limited availability and limited in size; must be reviewed and approved by PPTA. Contact Michelle Mason ASAP for more information.
Notepads (€ 2,500)
  • Your company logo will be printed on all notepads
Pens (€ 2,000)
  • Your company logo will be printed on all pens
Charging station (€ 1,500)
  • Charging station will be set up at a table that includes company signage. Brochures can be supplied by the sponsor.
Advertising Opportunities (€ 1,200)
  • Provide your company advertisement (brochure or flyer) to PPTA in advance and PPTA will include them in the IPPC handout materials.

Important Sponsorship Dates

Item

Due Date

Registration Form and Payment

8 April

Logo for branded product

15 April

Company Logo and a brief Word Description

29 April

Vimeo or YouTube Link

29 April

Flyers/Brochures

Must arrive by 8 June to PPTA Brussels Office:

PPTA, Boulevard Brand Whitlock 114/4, B-1200 Brussels, Belgium (Attn: Melanie Conrads)

“Ship your own” Products

Must arrive by 8 June to PPTA Brussels Office

Please fill out and return the sponsorship registration form to Michelle Mason.


Supporting Organisations

2015 A1FLogo Transparent COTT EPODIN
GBSCIDP Organisation Europe Logo HAEi MASTER LOGO 0519 HFALogo
IDF Logo ImmunodeficiencyUK logo strapline stacked IPOPI signature
ITP Logo Immune Transparent All 3D JM Logo Horizontal JPEG NHF 4c
PDSA standard logo WFH Logo Primary RGB new

PPTA Contacts
Hotel and Congress inquiries:
Melanie Conrads or +32.2.724.0188
Registration inquiries:
Charon Smith or +1.443.433.1114
Sponsorship and Exhibit inquiries:
Michelle Mason or +1.443.433.1106

Thank you 2022 IPPC Sponsors!


This detailed video takes viewers through all of the steps a first-time plasma donor would experience during the process of donating lifesaving plasma.


donatingplasma

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.


donatingplasma

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal
 Icon Twitter  Icon Facebook


donatingplasma

The need for plasma and plasma donors is more urgent than ever before. Visit givingplasma.org to learn more and to find a donation center near you.

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100